Skip to main content

The Value of Determination of Nuclear Oestrogen Receptors in Breast Cancer Biopsies

  • Chapter
Clinical Interest of Steroid Hormone Receptors in Breast Cancer

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 91))

Abstract

The oestrogen receptor status of the soluble fraction of a tumour biopsy is now accepted as a valuable tool in the management of advanced breast cancer [11]. Soluble receptor status of primary disease may also be of value as a prognostic index [3, 20], although this value might be limited to patients with intermediate nodal involvement [19]. However, the presence of soluble receptors alone is not an absolute index of hormonal dependence [22]. Hormone-receptor complex might fail to undergo translocation/activation [37] or to bind to the correct acceptor sites on the DNA [33]. Loss of hormonal dependence through a breakdown at the post-transcriptional level is also a possibility. For these reasons several parameters of oestrogen response have been studied in breast tumour biopsies. Measurement of the presence of progesterone receptor (a product of oestrogen action) has proved productive [11]. The suggestion that a useful index of hormonal dependence might simply be the presence of nuclear-bound oestrogen receptor [21] has been followed up by several groups [2, 15, 29, 38].

Work from our own laboratory was supported, in part, by the Cancer Research Campaign, to whom we are very grateful. C. L. is pleased to acknowledge receipt of a Medical Research Council studentship. We are much indebted to our various surgical colleagues and, in particular, to David Smith and Ken Calman

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson JN, Clark JH, Peck EJ Jr (1972) Oestrogen and nuclear binding sites: determination of specific sites by [3H] oestradiol exchange. Biochem J 126: 561–567

    PubMed  CAS  Google Scholar 

  2. Barnes DM, Skinner LG, Ribeiro GG (1979) Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer? Br J Cancer 40: 862–865

    Article  PubMed  CAS  Google Scholar 

  3. Bishop HM, Blarney RW, Elston CW, Haybittle JL, Nicholson RI, Griffiths K (1979) Relationship of oestrogen-receptor status to survival in breast cancer. Lancet 2: 283–284

    Article  PubMed  CAS  Google Scholar 

  4. Blankenstein MA, Peters-Mechielsen MJ, Mulder E, Van Der Molen HJ (1980) Estimation of total oestrogen receptors in DMB A-induced rat mammary tumors by exchange of nuclear bound ligand at low temperature; a comparison with rat uterus. J Steroid Biochem 13: 557–564

    Article  PubMed  CAS  Google Scholar 

  5. British Breast Group (1974) Assessment of response to treatment in advanced breast cancer. Lancet 2: 38–39

    Article  Google Scholar 

  6. Castagnetta L, Lo Casto M, Mercadante T, Polito L, Cowan S, Leake RE (1983) Intratumoural variation of oestrogen receptor status in endometrial cancer. Br J Cancer 47: 261–267

    Article  PubMed  CAS  Google Scholar 

  7. Chamness GC, McGuire WL (1980) Methods for analyzing steroid receptors in human breast cancer. In: McGuire WL (ed) Breast cancer, vol 3. Plenum Medical, New York, p 149

    Google Scholar 

  8. Clark JH, Peck EJ Jr (1976) Nuclear retention of receptor-oestrogen complex and nuclear acceptor sites. Nature 260: 635–637

    Article  PubMed  CAS  Google Scholar 

  9. Delarue JC, Bohoun C (1980) Utilization of the measurement of hormone receptors in the treatment of breast cancer in women. Ann Biol Clin (Paris) 38: 293–296

    CAS  Google Scholar 

  10. Duffy MJ, O’Connell M (1981) Estrogens, estradiol receptors and peroxidase activity in human mammary carcinomas. Eur J Cancer 17: 711–716

    Article  PubMed  CAS  Google Scholar 

  11. Edwards DP, Chamness GC, McGuire WL (1979) Estrogen and progesterone receptor proteins in breast cancer. Biochim Biophys Acta 560: 457–486

    PubMed  CAS  Google Scholar 

  12. Edwards DP, Martin PM, Horwitz KB, Chamness GC, McGuire WL (1980) Subcellular compartmentalization of estrogen receptors in human breast cancer cells. Exp Cell Res 127: 197–213

    Article  PubMed  CAS  Google Scholar 

  13. Fazekas AG, MacFarlane JK (1980) Studies on cytosol and nuclear binding of estradiol in human breast cancer. J Steroid Biochem 13: 613–622

    Article  PubMed  CAS  Google Scholar 

  14. Garola RE, McGuire WL (1977) An improved assay for nuclear oestrogen receptor in experimental and human breast cancer. Cancer Res 37: 3333–3337

    PubMed  CAS  Google Scholar 

  15. Hahnel R, Partridge RK, Gavet L, Twaddle E, Ratajczak T (1980) Nuclear and cytoplasmic estrogen receptors and progesterone receptors in breast cancer. Eur J Cancer 16: 1027–1033

    Article  PubMed  CAS  Google Scholar 

  16. Hawkins RA, Roberts MM, Forrest APM (1980) Oestrogen receptors and breast cancer: current status. Br J Surg 67: 152–169

    Article  Google Scholar 

  17. Hayward JL, Carbonne PP, Heuson JC, Kumaoka S, Segaloff A, Rubens RD (1977) Assessment of response to therapy in advanced breast cancer. Eur J Cancer 13: 89–94

    Article  Google Scholar 

  18. Horwitz KB, McGuire WL (1980) Nuclear estrogen receptors: effect of inhibitors on processing and steady state levels. J Biol Chem 255: 9699–9705

    PubMed  CAS  Google Scholar 

  19. Howat JMT, Barnes DM (1981) Oestrogen receptor status and management of breast cancer. Lancet 1: 1317

    Article  PubMed  CAS  Google Scholar 

  20. Knight WA, Livingston RB, Gregory EJ, McGuire WL (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671

    PubMed  CAS  Google Scholar 

  21. Laing L, Smith MG, Caiman KC, Smith DC, Leake RE (1977) Nuclear oestrogen receptors and treatment of breast cancer. Lancet 2: 168–169

    Article  PubMed  CAS  Google Scholar 

  22. Leake RE (1976) Current views on oestrogen receptors. Trends Biochem Sci 1: 137–139

    CAS  Google Scholar 

  23. Leake RE, Laing L, Smith DC (1979) A role for nuclear oestrogen receptors in prediction of therapy regime for breast cancer patients. In: King RJB (ed) Steroid receptor assays in human breast tumours. Alpha Omega, Cardiff, p 73

    Google Scholar 

  24. Leake RE (1980) Methodology of steroid hormone receptor determination in breast cancer. In: Taylor RW (ed) Progestogens in the management of hormonal responsive carcinomas. Medicine Publishing Foundation, Oxford, p 3

    Google Scholar 

  25. Leake RE, Laing L, Caiman KC, Macbeth FR, Crawford D, Smith DC (1981) Oestrogen-re¬ceptor status and endocrine therapy of breast cancer: response rates and status stability. Br J Cancer 43: 59–66

    Article  PubMed  CAS  Google Scholar 

  26. Leake RE, Laing L, McArdle C, Smith DC (1981) Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis. Br J Cancer 43: 67–71

    Article  PubMed  CAS  Google Scholar 

  27. MacFarlane JK, Fleiszer D, Fazekas AG (1980) Studies on estrogen receptors and regression in human breast cancer. Cancer 45: 2998–3003

    Article  PubMed  CAS  Google Scholar 

  28. Osborne CK, Yochmowitz MG, Knight WA, McGuire WL (1980) The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884–2888

    Article  PubMed  CAS  Google Scholar 

  29. Panko WB, MacLeod RM (1978) Uncharged nuclear receptors for estrogen in breast cancers. Cancer Res 38: 1948–1951

    PubMed  CAS  Google Scholar 

  30. Paridaens R, Sylvester RJ, Ferrazzi E, Legros N, Leclercq G, Heuson JC (1980) Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer 46: 2889–2895

    Article  PubMed  CAS  Google Scholar 

  31. Ruh TS, Baudendistel LJ (1977) Different nuclear binding sites for antiestrogen and estrogen receptor complexes. Endocrinology 100: 420–426

    Article  PubMed  CAS  Google Scholar 

  32. Samaan NA, Buzdar AU, Aldinger KA, Schultz PN, Yang KP, Romsdahl MM, Martin R (1981) Estrogen receptor: a prognostic factor in breast cancer. Cancer 47: 554–560

    Article  PubMed  CAS  Google Scholar 

  33. Sato B, Nomura Y, Nakao K, Ochi H, Matsumoto K (1981) DNA binding ability of estrogen receptor from human breast cancer. J Steroid Biochem 14: 295–303

    Article  PubMed  CAS  Google Scholar 

  34. Schoenberg DR, Clark JK (1980) A simple modification of the estrogen receptor exchange assay: validation in nuclei from the rat uterus and a mouse mammary tumor. Endocrinology 106: 56–60

    Article  PubMed  CAS  Google Scholar 

  35. Silfversward C, Skoog L, Humla S, Gustafsson SA, Nordenskjold B (1980) Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma. Eur J Cancer 16: 59–63

    Article  PubMed  CAS  Google Scholar 

  36. Taylor RN, Swaneck GE, Smith RG (1980) Correlation of nuclear acceptor sites for oestrogen receptors with gene transcription in vitro. Biochem J 192: 385–393

    PubMed  CAS  Google Scholar 

  37. Thorsen T, Stoa KF (1979) Nuclear uptake of oestradiol-17/3 in human mammary tumour tissue. J Steroid Biochem 10: 595–599

    PubMed  CAS  Google Scholar 

  38. Thorsen T (1980) Occupied and unoccupied oestradiol receptor in human breast tumour cytosol. J Steroid Biochem 13: 405–408

    Article  PubMed  CAS  Google Scholar 

  39. Tilley WD, Keightley DD, Cant ELM (1978) Inter-site variation of oestrogen receptors in human breast cancers. Br J Cancer 38: 544–546

    Article  PubMed  CAS  Google Scholar 

  40. Tisdale MJ (1977) Inhibition of prostaglandin synthetase by anti-tumour agents. Chem Biol Interact 18: 91–102

    Article  PubMed  CAS  Google Scholar 

  41. Zava DT, Harrington NY, McGuire WL (1976) Nuclear estradiol receptor in the adult rat uterus: a new exchange assay. Biochemistry 15: 4292–4297

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Cowan, S., Love, C., Leake, R.E. (1984). The Value of Determination of Nuclear Oestrogen Receptors in Breast Cancer Biopsies. In: Leclercq, G., Toma, S., Paridaens, R., Heuson, J.C. (eds) Clinical Interest of Steroid Hormone Receptors in Breast Cancer. Recent Results in Cancer Research, vol 91. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82188-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82188-2_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-82190-5

  • Online ISBN: 978-3-642-82188-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics